BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31112736)

  • 1. Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.
    Morad SAF; MacDougall MR; Abdelmageed N; Kao LP; Feith DJ; Tan SF; Kester M; Loughran TP; Wang HG; Cabot MC
    Exp Cell Res; 2019 Aug; 381(2):256-264. PubMed ID: 31112736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia.
    Morad SA; Ryan TE; Neufer PD; Zeczycki TN; Davis TS; MacDougall MR; Fox TE; Tan SF; Feith DJ; Loughran TP; Kester M; Claxton DF; Barth BM; Deering TG; Cabot MC
    J Lipid Res; 2016 Jul; 57(7):1231-42. PubMed ID: 27140664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML.
    Dany M; Gencer S; Nganga R; Thomas RJ; Oleinik N; Baron KD; Szulc ZM; Ruvolo P; Kornblau S; Andreeff M; Ogretmen B
    Blood; 2016 Oct; 128(15):1944-1958. PubMed ID: 27540013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.
    Morad SA; Tan SF; Feith DJ; Kester M; Claxton DF; Loughran TP; Barth BM; Fox TE; Cabot MC
    Biochim Biophys Acta; 2015 Jul; 1851(7):919-28. PubMed ID: 25769964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome-Induced Cell Death in Head and Neck Squamous Cell Carcinoma.
    Shaw JJP; Boyer TL; Venner E; Beck PJ; Slamowitz T; Caste T; Hickman A; Raymond MH; Costa-Pinheiro P; Jameson MJ; Fox TE; Kester M
    Mol Cancer Ther; 2020 Dec; 19(12):2621-2633. PubMed ID: 33087509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses.
    Wu SY; Wen YC; Ku CC; Yang YC; Chow JM; Yang SF; Lee WJ; Chien MH
    J Biomed Sci; 2019 Aug; 26(1):63. PubMed ID: 31470848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.
    Morad SA; Levin JC; Shanmugavelandy SS; Kester M; Fabrias G; Bedia C; Cabot MC
    Mol Cancer Ther; 2012 Nov; 11(11):2352-61. PubMed ID: 22962326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.
    Morad SAF; Davis TS; MacDougall MR; Tan SF; Feith DJ; Desai DH; Amin SG; Kester M; Loughran TP; Cabot MC
    Biochem Pharmacol; 2017 Apr; 130():21-33. PubMed ID: 28189725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia.
    Sumitomo Y; Koya J; Nakazaki K; Kataoka K; Tsuruta-Kishino T; Morita K; Sato T; Kurokawa M
    Blood; 2016 Sep; 128(12):1614-24. PubMed ID: 27480114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53.
    Morad SA; Madigan JP; Levin JC; Abdelmageed N; Karimi R; Rosenberg DW; Kester M; Shanmugavelandy SS; Cabot MC
    Biochem Pharmacol; 2013 Apr; 85(8):1057-65. PubMed ID: 23353700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.
    Bali P; George P; Cohen P; Tao J; Guo F; Sigua C; Vishvanath A; Scuto A; Annavarapu S; Fiskus W; Moscinski L; Atadja P; Bhalla K
    Clin Cancer Res; 2004 Aug; 10(15):4991-7. PubMed ID: 15297399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy.
    Sentelle RD; Senkal CE; Jiang W; Ponnusamy S; Gencer S; Selvam SP; Ramshesh VK; Peterson YK; Lemasters JJ; Szulc ZM; Bielawski J; Ogretmen B
    Nat Chem Biol; 2012 Oct; 8(10):831-8. PubMed ID: 22922758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
    Espinoza JL; Elbadry MI; Taniwaki M; Harada K; Trung LQ; Nakagawa N; Takami A; Ishiyama K; Yamauchi T; Takenaka K; Nakao S
    Cancer Lett; 2017 Aug; 400():127-136. PubMed ID: 28456658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
    Furlong SJ; Ridgway ND; Hoskin DW
    Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin increases leukemia cell sensitivity to chemotherapy by regulating mTORC1 pathway-mediated apoptosis and autophagy.
    Xu J; Zong S; Sheng T; Zheng J; Wu Q; Wang Q; Tang A; Song Y; Fei Y; Li Z
    Int J Hematol; 2024 May; 119(5):541-551. PubMed ID: 38530586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.
    Kim Y; Eom JI; Jeung HK; Jang JE; Kim JS; Cheong JW; Kim YS; Min YH
    Biomed Pharmacother; 2015 Jul; 73():87-96. PubMed ID: 26211587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
    Ghandour B; Dbaibo G; Darwiche N
    Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.
    Zhang W; Konopleva M; Shi YX; McQueen T; Harris D; Ling X; Estrov Z; Quintás-Cardama A; Small D; Cortes J; Andreeff M
    J Natl Cancer Inst; 2008 Feb; 100(3):184-98. PubMed ID: 18230792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide stress in survival versus lethal autophagy paradox: ceramide targets autophagosomes to mitochondria and induces lethal mitophagy.
    Jiang W; Ogretmen B
    Autophagy; 2013 Feb; 9(2):258-9. PubMed ID: 23182807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.